DE69805237D1 - Tumornekrose zugehöriger Rezeptor, TR4 - Google Patents

Tumornekrose zugehöriger Rezeptor, TR4

Info

Publication number
DE69805237D1
DE69805237D1 DE69805237T DE69805237T DE69805237D1 DE 69805237 D1 DE69805237 D1 DE 69805237D1 DE 69805237 T DE69805237 T DE 69805237T DE 69805237 T DE69805237 T DE 69805237T DE 69805237 D1 DE69805237 D1 DE 69805237D1
Authority
DE
Germany
Prior art keywords
tumor necrosis
associated receptor
necrosis associated
receptor
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69805237T
Other languages
English (en)
Inventor
John Emery
Kong B Tan
Alemseged Truneh
Peter R Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25163707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69805237(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE69805237D1 publication Critical patent/DE69805237D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69805237T 1997-02-04 1998-01-20 Tumornekrose zugehöriger Rezeptor, TR4 Expired - Lifetime DE69805237D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/794,796 US5885800A (en) 1997-02-04 1997-02-04 DNA encoding tumor necrosis related receptor, TR4

Publications (1)

Publication Number Publication Date
DE69805237D1 true DE69805237D1 (de) 2002-06-13

Family

ID=25163707

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69805237T Expired - Lifetime DE69805237D1 (de) 1997-02-04 1998-01-20 Tumornekrose zugehöriger Rezeptor, TR4

Country Status (5)

Country Link
US (1) US5885800A (de)
EP (1) EP0861850B1 (de)
JP (1) JPH10215886A (de)
CA (1) CA2220852A1 (de)
DE (1) DE69805237D1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192584B2 (en) 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
US20040013664A1 (en) * 1997-01-14 2004-01-22 Gentz Reiner L. Tumor necrosis factor receptors 6 alpha & 6 beta
EP1007659B1 (de) * 1997-01-14 2007-06-27 Human Genome Sciences, Inc. Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
US7285267B2 (en) * 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
AU9013998A (en) * 1997-07-21 1999-02-10 Zymogenetics Inc. Tumor necrosis factor receptor ztnfr-5
EP1019502A2 (de) * 1997-08-06 2000-07-19 Regeneron Pharmaceuticals, Inc. Humane waisenrezeptor ntr-1
WO1999011791A2 (en) * 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
US20040231011A1 (en) * 2001-06-28 2004-11-18 Genentech, Inc. DcR3 polypeptide, a TNFR homolog
IL134578A0 (en) * 1997-09-18 2001-04-30 Genentech Inc DcR3 POLYPEPTIDE, A TNFR HOMOLOG
WO1999026977A1 (en) * 1997-11-24 1999-06-03 Biogen, Inc. Novel receptors opg-2
EP1037908A2 (de) * 1997-12-16 2000-09-27 Incyte Pharmaceuticals, Inc. Menschlicher tumor nekrose factor r2-ähnlicher rezeptor
DE19809978A1 (de) * 1998-03-09 1999-09-16 Basf Ag Neuer Rezeptor aus der menschlichen Lunge
PL343847A1 (en) * 1998-03-30 2001-09-10 Lilly Co Eli Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
CA2344976A1 (en) * 1998-10-08 2000-04-13 Takeda Chemical Industries, Ltd. Novel g-protein-coupled receptor protein and its dna
US6916907B1 (en) * 1998-10-23 2005-07-12 Curagen Corporation Nucleic acids encoding osteoprotegern-like proteins and methods of using same
WO2000034782A1 (en) * 1998-12-09 2000-06-15 Eli Lilly And Company Flint compositions and uses thereof
WO2000037094A2 (en) * 1998-12-22 2000-06-29 Eli Lilly And Company Therapeutic applications of flint polypeptides
WO2000046247A1 (en) * 1999-02-05 2000-08-10 Merck & Co., Inc. Methods of use for dna molecules encoding m68, a tnf receptor-related protein
CN1345329A (zh) * 1999-03-04 2002-04-17 人体基因组科学有限公司 肿瘤坏死因子受体6α和6β
AU2495200A (en) * 1999-03-08 2000-09-28 Genentech Inc. Compositions and methods for the treatment of tumor
US6965012B1 (en) * 1999-03-30 2005-11-15 Eli Lilly And Company Flint polypeptide analogs
AU2215300A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
AU6517800A (en) * 1999-08-04 2001-03-05 Amgen, Inc. Ntr3, a member of the tnf-receptor supergene family
MXPA02001264A (es) * 1999-08-04 2002-07-22 Amgen Inc Fhm, nuevo miembro de la familia de supergenes de ligando de factor de necrosis tumoral.
WO2001018041A2 (en) * 1999-09-10 2001-03-15 Eli Lilly And Company Flint proteins and formulations thereof
CA2420593A1 (en) * 2000-08-25 2002-03-07 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6.alpha. and 6.beta.
US6824572B2 (en) * 2001-03-06 2004-11-30 Cargill, Incorporated Vegetable oil based wax compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741667A (en) * 1994-05-27 1998-04-21 Genentech, Inc. Tumor necrosis factor receptor-associated factors
WO1996028546A1 (en) * 1995-03-15 1996-09-19 Human Genome Sciences, Inc. Human tumor necrosis factor receptor

Also Published As

Publication number Publication date
US5885800A (en) 1999-03-23
JPH10215886A (ja) 1998-08-18
EP0861850B1 (de) 2002-05-08
CA2220852A1 (en) 1998-08-03
EP0861850A1 (de) 1998-09-02

Similar Documents

Publication Publication Date Title
DE69805237D1 (de) Tumornekrose zugehöriger Rezeptor, TR4
DE69727908D1 (de) Tumor-Nekrosis-Faktor verwandter Receptor, TR6
ATE382345T1 (de) Fluvastatin-arzneimittel mit verzögerter wirkstoffabgabe
DE59814019D1 (de) 2-benzoyl-cyclohexan-1,3-dione
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DZ2917A1 (fr) Nouveau 3-tetrahydropyridin-4-yl indoles.
MA24551A1 (fr) W.c.
DE59807073D1 (de) Substituierte 2-benzoyl-cyclohexan-1,3-dione
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
ES1041026Y (es) Vibrador terapeutico.
NL1011592A1 (nl) Ondersteuningsconstructie.
ES1038112Y (es) Archivador-encuadernador perfeccionado.
ES1044492Y (es) Parasol.
ES1037689Y (es) Bloque aislante perfeccionado.
ES1037770Y (es) Piñata perfeccionada.
ES1036758Y (es) Rubela perfeccionada.
FI971570A0 (fi) Styrsystem foer foerbraenningsluften i en ackumulerande, vedeldad eldstad
FI971438A0 (fi) Koppling laemplig foer spaennings- eller spaenningsfri arbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd
FI971391A0 (fi) Koppling laemplig foer spaenningsarbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd
ID19473A (id) 24-homo-26,27-heksafluoro-kolkalsiferol
FI3112U1 (fi) Maila, erityisesti pesäpallomaila
UA25266A (uk) Сталь, що цемеhтується
ES1036409Y (es) Zapatilla perfeccionada.
FI963062A0 (fi) Dubbelblad foer stoetblad, skopa, schaktblad
ES1036324Y (es) Cose-papeles mejorado.

Legal Events

Date Code Title Description
8332 No legal effect for de